JY
ONCR

Jeff Yass’s Oncorus, Inc. ONCR Stock Holding History

Jeff Yass’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,525
Closed -$6.03K – 13607
2023
Q1 		$6.03K Buy
+17,525
New +$6.54K ﹤0.01% 12281
2022
Q3 		– Sell
-41,192
Closed -$52K – 14500
2022
Q2 		$52K Buy
+41,192
New +$56K ﹤0.01% 11958
2022
Q1 		– Sell
-10,846
Closed -$57K – 14334
2021
Q4 		$57K Buy
+10,846
New +$84K ﹤0.01% 12483
2021
Q2 		– Sell
-35,130
Closed -$489K – 13497
2021
Q1 		$489K Buy
+35,130
New +$727K ﹤0.01% 9520

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Jeff Yass's ONCR Position: Q2 2023 in Review

Jeff Yass sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 17,525 shares — an estimated $6.03K sold.

Jeff Yass first reported a position in ONCR in Q1 2021 and held it in 4 quarters. The position peaked at $489K in Q1 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Jeff Yass reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 17,525 Oncorus, Inc. shares in Q2 2023, an estimated $6.03K.
  • Jeff Yass first reported a position in Oncorus, Inc. in Q1 2021 and held it in 4 quarters.
  • Jeff Yass's Oncorus, Inc. position peaked at $489K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.